nodes	percent_of_prediction	percent_of_DWPC	metapath
Paricalcitol—Ergocalciferol—rheumatoid arthritis	0.351	1	CrCtD
Paricalcitol—VDR—rheumatoid arthritis	0.149	1	CbGaD
Paricalcitol—CYP24A1—Ergocalciferol—rheumatoid arthritis	0.109	0.518	CbGbCtD
Paricalcitol—VDR—Ergocalciferol—rheumatoid arthritis	0.0864	0.411	CbGbCtD
Paricalcitol—Cholecalciferol—Ergocalciferol—rheumatoid arthritis	0.0393	0.167	CrCrCtD
Paricalcitol—Calcidiol—Ergocalciferol—rheumatoid arthritis	0.0393	0.167	CrCrCtD
Paricalcitol—Alfacalcidol—Ergocalciferol—rheumatoid arthritis	0.0393	0.167	CrCrCtD
Paricalcitol—Calcipotriol—Ergocalciferol—rheumatoid arthritis	0.0393	0.167	CrCrCtD
Paricalcitol—Dihydrotachysterol—Ergocalciferol—rheumatoid arthritis	0.0393	0.167	CrCrCtD
Paricalcitol—Calcitriol—Ergocalciferol—rheumatoid arthritis	0.0393	0.167	CrCrCtD
Paricalcitol—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.00308	0.0147	CbGbCtD
Paricalcitol—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.00227	0.0108	CbGbCtD
Paricalcitol—CYP24A1—Vitamin D (calciferol) metabolism—GC—rheumatoid arthritis	0.0018	0.164	CbGpPWpGaD
Paricalcitol—CYP3A4—Triamcinolone—rheumatoid arthritis	0.00172	0.0082	CbGbCtD
Paricalcitol—CYP3A4—Betamethasone—rheumatoid arthritis	0.00148	0.00703	CbGbCtD
Paricalcitol—CYP3A4—Prednisolone—rheumatoid arthritis	0.00146	0.00694	CbGbCtD
Paricalcitol—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.00138	0.00658	CbGbCtD
Paricalcitol—CYP3A4—Prednisone—rheumatoid arthritis	0.00138	0.00655	CbGbCtD
Paricalcitol—CYP24A1—Vitamin D Metabolism—GC—rheumatoid arthritis	0.00135	0.123	CbGpPWpGaD
Paricalcitol—CYP3A4—Cyclosporine—rheumatoid arthritis	0.0013	0.00621	CbGbCtD
Paricalcitol—VDR—Vitamin D Metabolism—GC—rheumatoid arthritis	0.00113	0.103	CbGpPWpGaD
Paricalcitol—CYP3A4—Dexamethasone—rheumatoid arthritis	0.000859	0.00409	CbGbCtD
Paricalcitol—CYP24A1—Metabolism of steroid hormones and vitamin D—GC—rheumatoid arthritis	0.000521	0.0474	CbGpPWpGaD
Paricalcitol—CYP24A1—Vitamin D Metabolism—VDR—rheumatoid arthritis	0.000484	0.0441	CbGpPWpGaD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—MED1—rheumatoid arthritis	0.000431	0.0392	CbGpPWpGaD
Paricalcitol—Alfacalcidol—GC—rheumatoid arthritis	0.000418	0.194	CrCbGaD
Paricalcitol—Calcitriol—GC—rheumatoid arthritis	0.000372	0.173	CrCbGaD
Paricalcitol—VDR—Validated transcriptional targets of deltaNp63 isoforms—RUNX1—rheumatoid arthritis	0.000293	0.0267	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—MED1—rheumatoid arthritis	0.000251	0.0229	CbGpPWpGaD
Paricalcitol—Dihydrotachysterol—VDR—rheumatoid arthritis	0.000237	0.11	CrCbGaD
Paricalcitol—Cholecalciferol—GC—rheumatoid arthritis	0.000226	0.105	CrCbGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—AHR—rheumatoid arthritis	0.000206	0.0187	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—RUNX1—rheumatoid arthritis	0.00019	0.0173	CbGpPWpGaD
Paricalcitol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—rheumatoid arthritis	0.000182	0.0166	CbGpPWpGaD
Paricalcitol—CYP3A4—Farnesoid X Receptor  Pathway—FKBP5—rheumatoid arthritis	0.000178	0.0162	CbGpPWpGaD
Paricalcitol—Calcipotriol—VDR—rheumatoid arthritis	0.000152	0.0709	CrCbGaD
Paricalcitol—Calcidiol—VDR—rheumatoid arthritis	0.000152	0.0709	CrCbGaD
Paricalcitol—Alfacalcidol—VDR—rheumatoid arthritis	0.000152	0.0709	CrCbGaD
Paricalcitol—VDR—Validated transcriptional targets of deltaNp63 isoforms—BDKRB2—rheumatoid arthritis	0.000151	0.0138	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—PRDM1—rheumatoid arthritis	0.000137	0.0125	CbGpPWpGaD
Paricalcitol—Calcitriol—VDR—rheumatoid arthritis	0.000136	0.0632	CrCbGaD
Paricalcitol—CYP24A1—Metabolism of steroid hormones and vitamin D—POMC—rheumatoid arthritis	0.000128	0.0117	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors—NR3C1—rheumatoid arthritis	0.000126	0.0114	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—ZNF184—rheumatoid arthritis	0.000119	0.0109	CbGpPWpGaD
Paricalcitol—VDR—Validated transcriptional targets of deltaNp63 isoforms—IL1A—rheumatoid arthritis	0.000115	0.0105	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—TNFRSF10A—rheumatoid arthritis	0.000114	0.0104	CbGpPWpGaD
Paricalcitol—Calcipotriol—MPO—rheumatoid arthritis	0.000114	0.0528	CrCbGaD
Paricalcitol—Ergocalciferol—VDR—rheumatoid arthritis	0.000109	0.0505	CrCbGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—GATA3—rheumatoid arthritis	0.000107	0.00973	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—NR3C1—rheumatoid arthritis	9.92e-05	0.00904	CbGpPWpGaD
Paricalcitol—VDR—Validated transcriptional targets of TAp63 isoforms—FAS—rheumatoid arthritis	9.18e-05	0.00836	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—FADS2—rheumatoid arthritis	9.06e-05	0.00825	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—IRF5—rheumatoid arthritis	8.49e-05	0.00773	CbGpPWpGaD
Paricalcitol—Cholecalciferol—VDR—rheumatoid arthritis	8.23e-05	0.0383	CrCbGaD
Paricalcitol—CYP24A1—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	7.94e-05	0.00723	CbGpPWpGaD
Paricalcitol—VDR—Retinoic acid receptors-mediated signaling—MAPK8—rheumatoid arthritis	7.88e-05	0.00718	CbGpPWpGaD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—rheumatoid arthritis	7.49e-05	0.00682	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—IL10—rheumatoid arthritis	7.4e-05	0.00675	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—CTSD—rheumatoid arthritis	7.1e-05	0.00647	CbGpPWpGaD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TNF—rheumatoid arthritis	6.99e-05	0.00637	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—NR3C1—rheumatoid arthritis	6.85e-05	0.00624	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IFNG—rheumatoid arthritis	6.53e-05	0.00595	CbGpPWpGaD
Paricalcitol—CYP24A1—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	6.44e-05	0.00586	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—BDKRB2—rheumatoid arthritis	6.31e-05	0.00574	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	6.04e-05	0.00551	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IL1B—rheumatoid arthritis	5.83e-05	0.00531	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IL2—rheumatoid arthritis	5.8e-05	0.00529	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—ZNF184—rheumatoid arthritis	5.74e-05	0.00523	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	5.34e-05	0.00486	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	5.34e-05	0.00486	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	4.96e-05	0.00452	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—RBPJ—rheumatoid arthritis	4.57e-05	0.00416	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TGFB1—rheumatoid arthritis	4.53e-05	0.00412	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—SPP1—rheumatoid arthritis	4.44e-05	0.00405	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	4.35e-05	0.00396	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—MED1—rheumatoid arthritis	4.34e-05	0.00395	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—FAS—rheumatoid arthritis	4.28e-05	0.0039	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—AGER—rheumatoid arthritis	4.25e-05	0.00387	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TNF—rheumatoid arthritis	4.23e-05	0.00385	CbGpPWpGaD
Paricalcitol—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—rheumatoid arthritis	4.11e-05	0.00374	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—FADS2—rheumatoid arthritis	4.03e-05	0.00367	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—POMC—rheumatoid arthritis	3.42e-05	0.00311	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	3.35e-05	0.00305	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—HNRNPA2B1—rheumatoid arthritis	3.29e-05	0.003	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—FADS2—rheumatoid arthritis	3.22e-05	0.00294	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—MMP2—rheumatoid arthritis	3.14e-05	0.00286	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—DDX6—rheumatoid arthritis	3.01e-05	0.00274	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—POMC—rheumatoid arthritis	2.73e-05	0.00249	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PLD4—rheumatoid arthritis	2.69e-05	0.00245	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ACAN—rheumatoid arthritis	2.6e-05	0.00237	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—ZFP36—rheumatoid arthritis	2.5e-05	0.00227	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—UBE2D1—rheumatoid arthritis	2.49e-05	0.00227	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—SLC25A12—rheumatoid arthritis	2.44e-05	0.00223	CbGpPWpGaD
Paricalcitol—Insomnia—Hydrocortisone—rheumatoid arthritis	2.4e-05	0.000592	CcSEcCtD
Paricalcitol—Hypertension—Betamethasone—rheumatoid arthritis	2.4e-05	0.000592	CcSEcCtD
Paricalcitol—Hypertension—Dexamethasone—rheumatoid arthritis	2.4e-05	0.000592	CcSEcCtD
Paricalcitol—Paraesthesia—Hydrocortisone—rheumatoid arthritis	2.38e-05	0.000588	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—GC—rheumatoid arthritis	2.38e-05	0.00217	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PTGES—rheumatoid arthritis	2.38e-05	0.00217	CbGpPWpGaD
Paricalcitol—Urticaria—Cyclosporine—rheumatoid arthritis	2.37e-05	0.000585	CcSEcCtD
Paricalcitol—Myalgia—Betamethasone—rheumatoid arthritis	2.36e-05	0.000583	CcSEcCtD
Paricalcitol—Myalgia—Dexamethasone—rheumatoid arthritis	2.36e-05	0.000583	CcSEcCtD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—rheumatoid arthritis	2.36e-05	0.00215	CbGpPWpGaD
Paricalcitol—Body temperature increased—Cyclosporine—rheumatoid arthritis	2.36e-05	0.000582	CcSEcCtD
Paricalcitol—Abdominal pain—Cyclosporine—rheumatoid arthritis	2.36e-05	0.000582	CcSEcCtD
Paricalcitol—Anxiety—Betamethasone—rheumatoid arthritis	2.35e-05	0.000581	CcSEcCtD
Paricalcitol—Anxiety—Dexamethasone—rheumatoid arthritis	2.35e-05	0.000581	CcSEcCtD
Paricalcitol—Discomfort—Dexamethasone—rheumatoid arthritis	2.33e-05	0.000576	CcSEcCtD
Paricalcitol—Discomfort—Betamethasone—rheumatoid arthritis	2.33e-05	0.000576	CcSEcCtD
Paricalcitol—Dyspepsia—Hydrocortisone—rheumatoid arthritis	2.33e-05	0.000576	CcSEcCtD
Paricalcitol—Hypotension—Methylprednisolone—rheumatoid arthritis	2.33e-05	0.000575	CcSEcCtD
Paricalcitol—Pain—Prednisolone—rheumatoid arthritis	2.32e-05	0.000573	CcSEcCtD
Paricalcitol—Decreased appetite—Hydrocortisone—rheumatoid arthritis	2.3e-05	0.000569	CcSEcCtD
Paricalcitol—Pharyngitis—Methotrexate—rheumatoid arthritis	2.3e-05	0.000569	CcSEcCtD
Paricalcitol—Nausea—Leflunomide—rheumatoid arthritis	2.3e-05	0.000567	CcSEcCtD
Paricalcitol—Urinary tract disorder—Methotrexate—rheumatoid arthritis	2.29e-05	0.000566	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	2.29e-05	0.000565	CcSEcCtD
Paricalcitol—Fatigue—Hydrocortisone—rheumatoid arthritis	2.29e-05	0.000564	CcSEcCtD
Paricalcitol—Urethral disorder—Methotrexate—rheumatoid arthritis	2.27e-05	0.000562	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	2.27e-05	0.000562	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	2.27e-05	0.00056	CcSEcCtD
Paricalcitol—Pain—Hydrocortisone—rheumatoid arthritis	2.27e-05	0.00056	CcSEcCtD
Paricalcitol—Oedema—Dexamethasone—rheumatoid arthritis	2.26e-05	0.000559	CcSEcCtD
Paricalcitol—Oedema—Betamethasone—rheumatoid arthritis	2.26e-05	0.000559	CcSEcCtD
Paricalcitol—Insomnia—Triamcinolone—rheumatoid arthritis	2.26e-05	0.000557	CcSEcCtD
Paricalcitol—Insomnia—Methylprednisolone—rheumatoid arthritis	2.25e-05	0.000556	CcSEcCtD
Paricalcitol—Infection—Betamethasone—rheumatoid arthritis	2.25e-05	0.000556	CcSEcCtD
Paricalcitol—Infection—Dexamethasone—rheumatoid arthritis	2.25e-05	0.000556	CcSEcCtD
Paricalcitol—Ill-defined disorder—Prednisone—rheumatoid arthritis	2.24e-05	0.000554	CcSEcCtD
Paricalcitol—Paraesthesia—Triamcinolone—rheumatoid arthritis	2.24e-05	0.000553	CcSEcCtD
Paricalcitol—Feeling abnormal—Prednisolone—rheumatoid arthritis	2.24e-05	0.000552	CcSEcCtD
Paricalcitol—Paraesthesia—Methylprednisolone—rheumatoid arthritis	2.24e-05	0.000552	CcSEcCtD
Paricalcitol—Anaemia—Prednisone—rheumatoid arthritis	2.23e-05	0.000552	CcSEcCtD
Paricalcitol—Shock—Betamethasone—rheumatoid arthritis	2.23e-05	0.00055	CcSEcCtD
Paricalcitol—Shock—Dexamethasone—rheumatoid arthritis	2.23e-05	0.00055	CcSEcCtD
Paricalcitol—Dyspnoea—Triamcinolone—rheumatoid arthritis	2.22e-05	0.000549	CcSEcCtD
Paricalcitol—Nervous system disorder—Betamethasone—rheumatoid arthritis	2.22e-05	0.000548	CcSEcCtD
Paricalcitol—Nervous system disorder—Dexamethasone—rheumatoid arthritis	2.22e-05	0.000548	CcSEcCtD
Paricalcitol—Agitation—Prednisone—rheumatoid arthritis	2.22e-05	0.000548	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—PLB1—rheumatoid arthritis	2.21e-05	0.00201	CbGpPWpGaD
Paricalcitol—Angioedema—Prednisone—rheumatoid arthritis	2.21e-05	0.000545	CcSEcCtD
Paricalcitol—VDR—Gene Expression—RBPJ—rheumatoid arthritis	2.2e-05	0.002	CbGpPWpGaD
Paricalcitol—Hypersensitivity—Cyclosporine—rheumatoid arthritis	2.2e-05	0.000543	CcSEcCtD
Paricalcitol—Dyspepsia—Triamcinolone—rheumatoid arthritis	2.2e-05	0.000543	CcSEcCtD
Paricalcitol—Dyspepsia—Methylprednisolone—rheumatoid arthritis	2.19e-05	0.000541	CcSEcCtD
Paricalcitol—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	2.19e-05	0.000541	CcSEcCtD
Paricalcitol—Hyperhidrosis—Betamethasone—rheumatoid arthritis	2.19e-05	0.000541	CcSEcCtD
Paricalcitol—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	2.18e-05	0.000539	CcSEcCtD
Paricalcitol—Malaise—Prednisone—rheumatoid arthritis	2.18e-05	0.000538	CcSEcCtD
Paricalcitol—Vertigo—Prednisone—rheumatoid arthritis	2.17e-05	0.000536	CcSEcCtD
Paricalcitol—Eye disorder—Methotrexate—rheumatoid arthritis	2.17e-05	0.000535	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	2.17e-05	0.000535	CcSEcCtD
Paricalcitol—Syncope—Prednisone—rheumatoid arthritis	2.17e-05	0.000535	CcSEcCtD
Paricalcitol—Anorexia—Dexamethasone—rheumatoid arthritis	2.16e-05	0.000533	CcSEcCtD
Paricalcitol—Anorexia—Betamethasone—rheumatoid arthritis	2.16e-05	0.000533	CcSEcCtD
Paricalcitol—Urticaria—Prednisolone—rheumatoid arthritis	2.16e-05	0.000532	CcSEcCtD
Paricalcitol—Cardiac disorder—Methotrexate—rheumatoid arthritis	2.15e-05	0.000532	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—PLD4—rheumatoid arthritis	2.15e-05	0.00196	CbGpPWpGaD
Paricalcitol—Fatigue—Triamcinolone—rheumatoid arthritis	2.15e-05	0.000531	CcSEcCtD
Paricalcitol—Fatigue—Methylprednisolone—rheumatoid arthritis	2.15e-05	0.00053	CcSEcCtD
Paricalcitol—Asthenia—Cyclosporine—rheumatoid arthritis	2.14e-05	0.000528	CcSEcCtD
Paricalcitol—Pain—Triamcinolone—rheumatoid arthritis	2.13e-05	0.000527	CcSEcCtD
Paricalcitol—Loss of consciousness—Prednisone—rheumatoid arthritis	2.12e-05	0.000524	CcSEcCtD
Paricalcitol—VDR—Gene Expression—TNFSF13—rheumatoid arthritis	2.12e-05	0.00193	CbGpPWpGaD
Paricalcitol—Hypotension—Betamethasone—rheumatoid arthritis	2.12e-05	0.000523	CcSEcCtD
Paricalcitol—Hypotension—Dexamethasone—rheumatoid arthritis	2.12e-05	0.000523	CcSEcCtD
Paricalcitol—Pruritus—Cyclosporine—rheumatoid arthritis	2.11e-05	0.000521	CcSEcCtD
Paricalcitol—Urticaria—Hydrocortisone—rheumatoid arthritis	2.11e-05	0.00052	CcSEcCtD
Paricalcitol—Angiopathy—Methotrexate—rheumatoid arthritis	2.1e-05	0.00052	CcSEcCtD
Paricalcitol—Immune system disorder—Methotrexate—rheumatoid arthritis	2.1e-05	0.000517	CcSEcCtD
Paricalcitol—Body temperature increased—Hydrocortisone—rheumatoid arthritis	2.1e-05	0.000517	CcSEcCtD
Paricalcitol—Abdominal pain—Hydrocortisone—rheumatoid arthritis	2.1e-05	0.000517	CcSEcCtD
Paricalcitol—Mediastinal disorder—Methotrexate—rheumatoid arthritis	2.09e-05	0.000516	CcSEcCtD
Paricalcitol—VDR—Gene Expression—MED1—rheumatoid arthritis	2.09e-05	0.0019	CbGpPWpGaD
Paricalcitol—Hypertension—Prednisone—rheumatoid arthritis	2.09e-05	0.000515	CcSEcCtD
Paricalcitol—Chills—Methotrexate—rheumatoid arthritis	2.08e-05	0.000514	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—ACAN—rheumatoid arthritis	2.08e-05	0.00189	CbGpPWpGaD
Paricalcitol—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	2.06e-05	0.000509	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	2.06e-05	0.000509	CcSEcCtD
Paricalcitol—Myalgia—Prednisone—rheumatoid arthritis	2.06e-05	0.000508	CcSEcCtD
Paricalcitol—Arthralgia—Prednisone—rheumatoid arthritis	2.06e-05	0.000508	CcSEcCtD
Paricalcitol—Feeling abnormal—Triamcinolone—rheumatoid arthritis	2.06e-05	0.000508	CcSEcCtD
Paricalcitol—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	2.05e-05	0.000507	CcSEcCtD
Paricalcitol—Anxiety—Prednisone—rheumatoid arthritis	2.05e-05	0.000506	CcSEcCtD
Paricalcitol—Alopecia—Methotrexate—rheumatoid arthritis	2.05e-05	0.000506	CcSEcCtD
Paricalcitol—Insomnia—Betamethasone—rheumatoid arthritis	2.05e-05	0.000506	CcSEcCtD
Paricalcitol—Insomnia—Dexamethasone—rheumatoid arthritis	2.05e-05	0.000506	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	2.04e-05	0.000505	CcSEcCtD
Paricalcitol—Diarrhoea—Cyclosporine—rheumatoid arthritis	2.04e-05	0.000504	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	2.04e-05	0.000503	CcSEcCtD
Paricalcitol—Paraesthesia—Dexamethasone—rheumatoid arthritis	2.03e-05	0.000502	CcSEcCtD
Paricalcitol—Paraesthesia—Betamethasone—rheumatoid arthritis	2.03e-05	0.000502	CcSEcCtD
Paricalcitol—Discomfort—Prednisone—rheumatoid arthritis	2.03e-05	0.000502	CcSEcCtD
Paricalcitol—Mental disorder—Methotrexate—rheumatoid arthritis	2.03e-05	0.000502	CcSEcCtD
Paricalcitol—Malnutrition—Methotrexate—rheumatoid arthritis	2.02e-05	0.000499	CcSEcCtD
Paricalcitol—Hypersensitivity—Prednisolone—rheumatoid arthritis	2e-05	0.000494	CcSEcCtD
Paricalcitol—Dyspepsia—Dexamethasone—rheumatoid arthritis	1.99e-05	0.000492	CcSEcCtD
Paricalcitol—Dyspepsia—Betamethasone—rheumatoid arthritis	1.99e-05	0.000492	CcSEcCtD
Paricalcitol—Urticaria—Triamcinolone—rheumatoid arthritis	1.98e-05	0.00049	CcSEcCtD
Paricalcitol—Urticaria—Methylprednisolone—rheumatoid arthritis	1.98e-05	0.000489	CcSEcCtD
Paricalcitol—Dysgeusia—Methotrexate—rheumatoid arthritis	1.98e-05	0.000488	CcSEcCtD
Paricalcitol—Body temperature increased—Triamcinolone—rheumatoid arthritis	1.97e-05	0.000487	CcSEcCtD
Paricalcitol—Dizziness—Cyclosporine—rheumatoid arthritis	1.97e-05	0.000487	CcSEcCtD
Paricalcitol—Oedema—Prednisone—rheumatoid arthritis	1.97e-05	0.000487	CcSEcCtD
Paricalcitol—Abdominal pain—Methylprednisolone—rheumatoid arthritis	1.97e-05	0.000486	CcSEcCtD
Paricalcitol—Decreased appetite—Dexamethasone—rheumatoid arthritis	1.97e-05	0.000486	CcSEcCtD
Paricalcitol—Decreased appetite—Betamethasone—rheumatoid arthritis	1.97e-05	0.000486	CcSEcCtD
Paricalcitol—Infection—Prednisone—rheumatoid arthritis	1.96e-05	0.000484	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	1.95e-05	0.000483	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	1.95e-05	0.000483	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—SLC25A12—rheumatoid arthritis	1.95e-05	0.00178	CbGpPWpGaD
Paricalcitol—Back pain—Methotrexate—rheumatoid arthritis	1.95e-05	0.000482	CcSEcCtD
Paricalcitol—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	1.95e-05	0.000482	CcSEcCtD
Paricalcitol—Fatigue—Betamethasone—rheumatoid arthritis	1.95e-05	0.000482	CcSEcCtD
Paricalcitol—Fatigue—Dexamethasone—rheumatoid arthritis	1.95e-05	0.000482	CcSEcCtD
Paricalcitol—Shock—Prednisone—rheumatoid arthritis	1.94e-05	0.000479	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—MED1—rheumatoid arthritis	1.94e-05	0.00177	CbGpPWpGaD
Paricalcitol—Pain—Dexamethasone—rheumatoid arthritis	1.94e-05	0.000478	CcSEcCtD
Paricalcitol—Pain—Betamethasone—rheumatoid arthritis	1.94e-05	0.000478	CcSEcCtD
Paricalcitol—Nervous system disorder—Prednisone—rheumatoid arthritis	1.93e-05	0.000478	CcSEcCtD
Paricalcitol—Skin disorder—Prednisone—rheumatoid arthritis	1.92e-05	0.000473	CcSEcCtD
Paricalcitol—CYP3A4—Tryptophan metabolism—CAT—rheumatoid arthritis	1.91e-05	0.00174	CbGpPWpGaD
Paricalcitol—Hyperhidrosis—Prednisone—rheumatoid arthritis	1.91e-05	0.000471	CcSEcCtD
Paricalcitol—Asthenia—Hydrocortisone—rheumatoid arthritis	1.9e-05	0.00047	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—PTGES—rheumatoid arthritis	1.9e-05	0.00173	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GC—rheumatoid arthritis	1.9e-05	0.00173	CbGpPWpGaD
Paricalcitol—Vomiting—Cyclosporine—rheumatoid arthritis	1.9e-05	0.000468	CcSEcCtD
Paricalcitol—Rash—Cyclosporine—rheumatoid arthritis	1.88e-05	0.000464	CcSEcCtD
Paricalcitol—Anorexia—Prednisone—rheumatoid arthritis	1.88e-05	0.000464	CcSEcCtD
Paricalcitol—Dermatitis—Cyclosporine—rheumatoid arthritis	1.88e-05	0.000464	CcSEcCtD
Paricalcitol—Pruritus—Hydrocortisone—rheumatoid arthritis	1.88e-05	0.000463	CcSEcCtD
Paricalcitol—Ill-defined disorder—Methotrexate—rheumatoid arthritis	1.87e-05	0.000463	CcSEcCtD
Paricalcitol—Headache—Cyclosporine—rheumatoid arthritis	1.87e-05	0.000461	CcSEcCtD
Paricalcitol—Anaemia—Methotrexate—rheumatoid arthritis	1.87e-05	0.000461	CcSEcCtD
Paricalcitol—Feeling abnormal—Dexamethasone—rheumatoid arthritis	1.87e-05	0.000461	CcSEcCtD
Paricalcitol—Feeling abnormal—Betamethasone—rheumatoid arthritis	1.87e-05	0.000461	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	1.85e-05	0.000457	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	1.85e-05	0.000457	CcSEcCtD
Paricalcitol—Hypersensitivity—Triamcinolone—rheumatoid arthritis	1.84e-05	0.000454	CcSEcCtD
Paricalcitol—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	1.83e-05	0.000453	CcSEcCtD
Paricalcitol—Malaise—Methotrexate—rheumatoid arthritis	1.82e-05	0.00045	CcSEcCtD
Paricalcitol—Vertigo—Methotrexate—rheumatoid arthritis	1.81e-05	0.000448	CcSEcCtD
Paricalcitol—Diarrhoea—Hydrocortisone—rheumatoid arthritis	1.81e-05	0.000448	CcSEcCtD
Paricalcitol—Leukopenia—Methotrexate—rheumatoid arthritis	1.81e-05	0.000446	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—ACP5—rheumatoid arthritis	1.8e-05	0.00164	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—B3GNT2—rheumatoid arthritis	1.8e-05	0.00164	CbGpPWpGaD
Paricalcitol—Urticaria—Betamethasone—rheumatoid arthritis	1.8e-05	0.000444	CcSEcCtD
Paricalcitol—Urticaria—Dexamethasone—rheumatoid arthritis	1.8e-05	0.000444	CcSEcCtD
Paricalcitol—UGT1A4—NRF2 pathway—TGFB1—rheumatoid arthritis	1.8e-05	0.00164	CbGpPWpGaD
Paricalcitol—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	1.8e-05	0.000444	CcSEcCtD
Paricalcitol—Dizziness—Prednisolone—rheumatoid arthritis	1.79e-05	0.000443	CcSEcCtD
Paricalcitol—Asthenia—Triamcinolone—rheumatoid arthritis	1.79e-05	0.000442	CcSEcCtD
Paricalcitol—Body temperature increased—Dexamethasone—rheumatoid arthritis	1.79e-05	0.000442	CcSEcCtD
Paricalcitol—Abdominal pain—Betamethasone—rheumatoid arthritis	1.79e-05	0.000442	CcSEcCtD
Paricalcitol—Abdominal pain—Dexamethasone—rheumatoid arthritis	1.79e-05	0.000442	CcSEcCtD
Paricalcitol—Body temperature increased—Betamethasone—rheumatoid arthritis	1.79e-05	0.000442	CcSEcCtD
Paricalcitol—Asthenia—Methylprednisolone—rheumatoid arthritis	1.79e-05	0.000441	CcSEcCtD
Paricalcitol—Insomnia—Prednisone—rheumatoid arthritis	1.78e-05	0.00044	CcSEcCtD
Paricalcitol—Nausea—Cyclosporine—rheumatoid arthritis	1.77e-05	0.000437	CcSEcCtD
Paricalcitol—Paraesthesia—Prednisone—rheumatoid arthritis	1.77e-05	0.000437	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—PLB1—rheumatoid arthritis	1.77e-05	0.00161	CbGpPWpGaD
Paricalcitol—Pruritus—Triamcinolone—rheumatoid arthritis	1.77e-05	0.000436	CcSEcCtD
Paricalcitol—Cough—Methotrexate—rheumatoid arthritis	1.76e-05	0.000435	CcSEcCtD
Paricalcitol—Pruritus—Methylprednisolone—rheumatoid arthritis	1.76e-05	0.000435	CcSEcCtD
Paricalcitol—Dizziness—Hydrocortisone—rheumatoid arthritis	1.75e-05	0.000433	CcSEcCtD
Paricalcitol—Dyspepsia—Prednisone—rheumatoid arthritis	1.74e-05	0.000429	CcSEcCtD
Paricalcitol—Chest pain—Methotrexate—rheumatoid arthritis	1.72e-05	0.000425	CcSEcCtD
Paricalcitol—Arthralgia—Methotrexate—rheumatoid arthritis	1.72e-05	0.000425	CcSEcCtD
Paricalcitol—Myalgia—Methotrexate—rheumatoid arthritis	1.72e-05	0.000425	CcSEcCtD
Paricalcitol—Decreased appetite—Prednisone—rheumatoid arthritis	1.71e-05	0.000423	CcSEcCtD
Paricalcitol—VDR—Generic Transcription Pathway—NR3C1—rheumatoid arthritis	1.71e-05	0.00156	CbGpPWpGaD
Paricalcitol—Rash—Prednisolone—rheumatoid arthritis	1.71e-05	0.000423	CcSEcCtD
Paricalcitol—Dermatitis—Prednisolone—rheumatoid arthritis	1.71e-05	0.000422	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	1.71e-05	0.000422	CcSEcCtD
Paricalcitol—Diarrhoea—Methylprednisolone—rheumatoid arthritis	1.7e-05	0.000421	CcSEcCtD
Paricalcitol—Fatigue—Prednisone—rheumatoid arthritis	1.7e-05	0.00042	CcSEcCtD
Paricalcitol—Headache—Prednisolone—rheumatoid arthritis	1.7e-05	0.00042	CcSEcCtD
Paricalcitol—Discomfort—Methotrexate—rheumatoid arthritis	1.7e-05	0.000419	CcSEcCtD
Paricalcitol—Constipation—Prednisone—rheumatoid arthritis	1.69e-05	0.000416	CcSEcCtD
Paricalcitol—Vomiting—Hydrocortisone—rheumatoid arthritis	1.69e-05	0.000416	CcSEcCtD
Paricalcitol—Rash—Hydrocortisone—rheumatoid arthritis	1.67e-05	0.000413	CcSEcCtD
Paricalcitol—Dermatitis—Hydrocortisone—rheumatoid arthritis	1.67e-05	0.000412	CcSEcCtD
Paricalcitol—Confusional state—Methotrexate—rheumatoid arthritis	1.66e-05	0.00041	CcSEcCtD
Paricalcitol—Headache—Hydrocortisone—rheumatoid arthritis	1.66e-05	0.00041	CcSEcCtD
Paricalcitol—Dizziness—Triamcinolone—rheumatoid arthritis	1.65e-05	0.000408	CcSEcCtD
Paricalcitol—Dizziness—Methylprednisolone—rheumatoid arthritis	1.65e-05	0.000407	CcSEcCtD
Paricalcitol—Infection—Methotrexate—rheumatoid arthritis	1.64e-05	0.000404	CcSEcCtD
Paricalcitol—Feeling abnormal—Prednisone—rheumatoid arthritis	1.63e-05	0.000401	CcSEcCtD
Paricalcitol—Asthenia—Dexamethasone—rheumatoid arthritis	1.62e-05	0.000401	CcSEcCtD
Paricalcitol—Asthenia—Betamethasone—rheumatoid arthritis	1.62e-05	0.000401	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—BGN—rheumatoid arthritis	1.62e-05	0.00148	CbGpPWpGaD
Paricalcitol—Nervous system disorder—Methotrexate—rheumatoid arthritis	1.62e-05	0.000399	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Prednisone—rheumatoid arthritis	1.61e-05	0.000398	CcSEcCtD
Paricalcitol—Nausea—Prednisolone—rheumatoid arthritis	1.61e-05	0.000398	CcSEcCtD
Paricalcitol—VDR—Direct p53 effectors—TP53—rheumatoid arthritis	1.6e-05	0.00146	CbGpPWpGaD
Paricalcitol—Pruritus—Dexamethasone—rheumatoid arthritis	1.6e-05	0.000396	CcSEcCtD
Paricalcitol—Pruritus—Betamethasone—rheumatoid arthritis	1.6e-05	0.000396	CcSEcCtD
Paricalcitol—Skin disorder—Methotrexate—rheumatoid arthritis	1.6e-05	0.000395	CcSEcCtD
Paricalcitol—Hyperhidrosis—Methotrexate—rheumatoid arthritis	1.59e-05	0.000393	CcSEcCtD
Paricalcitol—Vomiting—Triamcinolone—rheumatoid arthritis	1.59e-05	0.000392	CcSEcCtD
Paricalcitol—Vomiting—Methylprednisolone—rheumatoid arthritis	1.58e-05	0.000391	CcSEcCtD
Paricalcitol—Nausea—Hydrocortisone—rheumatoid arthritis	1.57e-05	0.000389	CcSEcCtD
Paricalcitol—Rash—Triamcinolone—rheumatoid arthritis	1.57e-05	0.000389	CcSEcCtD
Paricalcitol—Dermatitis—Triamcinolone—rheumatoid arthritis	1.57e-05	0.000388	CcSEcCtD
Paricalcitol—Anorexia—Methotrexate—rheumatoid arthritis	1.57e-05	0.000388	CcSEcCtD
Paricalcitol—Rash—Methylprednisolone—rheumatoid arthritis	1.57e-05	0.000388	CcSEcCtD
Paricalcitol—Dermatitis—Methylprednisolone—rheumatoid arthritis	1.57e-05	0.000387	CcSEcCtD
Paricalcitol—Urticaria—Prednisone—rheumatoid arthritis	1.57e-05	0.000387	CcSEcCtD
Paricalcitol—Headache—Triamcinolone—rheumatoid arthritis	1.56e-05	0.000386	CcSEcCtD
Paricalcitol—Headache—Methylprednisolone—rheumatoid arthritis	1.56e-05	0.000385	CcSEcCtD
Paricalcitol—Abdominal pain—Prednisone—rheumatoid arthritis	1.56e-05	0.000385	CcSEcCtD
Paricalcitol—Body temperature increased—Prednisone—rheumatoid arthritis	1.56e-05	0.000385	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—MED1—rheumatoid arthritis	1.55e-05	0.00141	CbGpPWpGaD
Paricalcitol—Diarrhoea—Betamethasone—rheumatoid arthritis	1.55e-05	0.000383	CcSEcCtD
Paricalcitol—Diarrhoea—Dexamethasone—rheumatoid arthritis	1.55e-05	0.000383	CcSEcCtD
Paricalcitol—Hypotension—Methotrexate—rheumatoid arthritis	1.54e-05	0.00038	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	1.5e-05	0.000371	CcSEcCtD
Paricalcitol—Dizziness—Dexamethasone—rheumatoid arthritis	1.5e-05	0.00037	CcSEcCtD
Paricalcitol—Dizziness—Betamethasone—rheumatoid arthritis	1.5e-05	0.00037	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—ALOX5—rheumatoid arthritis	1.49e-05	0.00136	CbGpPWpGaD
Paricalcitol—Insomnia—Methotrexate—rheumatoid arthritis	1.49e-05	0.000368	CcSEcCtD
Paricalcitol—Nausea—Triamcinolone—rheumatoid arthritis	1.48e-05	0.000366	CcSEcCtD
Paricalcitol—Paraesthesia—Methotrexate—rheumatoid arthritis	1.48e-05	0.000365	CcSEcCtD
Paricalcitol—Nausea—Methylprednisolone—rheumatoid arthritis	1.48e-05	0.000365	CcSEcCtD
Paricalcitol—Dyspnoea—Methotrexate—rheumatoid arthritis	1.47e-05	0.000363	CcSEcCtD
Paricalcitol—Somnolence—Methotrexate—rheumatoid arthritis	1.47e-05	0.000362	CcSEcCtD
Paricalcitol—Hypersensitivity—Prednisone—rheumatoid arthritis	1.45e-05	0.000359	CcSEcCtD
Paricalcitol—Dyspepsia—Methotrexate—rheumatoid arthritis	1.45e-05	0.000358	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—B3GNT2—rheumatoid arthritis	1.44e-05	0.00131	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ACP5—rheumatoid arthritis	1.44e-05	0.00131	CbGpPWpGaD
Paricalcitol—Vomiting—Dexamethasone—rheumatoid arthritis	1.44e-05	0.000356	CcSEcCtD
Paricalcitol—Vomiting—Betamethasone—rheumatoid arthritis	1.44e-05	0.000356	CcSEcCtD
Paricalcitol—Decreased appetite—Methotrexate—rheumatoid arthritis	1.43e-05	0.000354	CcSEcCtD
Paricalcitol—Rash—Dexamethasone—rheumatoid arthritis	1.43e-05	0.000353	CcSEcCtD
Paricalcitol—Rash—Betamethasone—rheumatoid arthritis	1.43e-05	0.000353	CcSEcCtD
Paricalcitol—Dermatitis—Dexamethasone—rheumatoid arthritis	1.43e-05	0.000352	CcSEcCtD
Paricalcitol—Dermatitis—Betamethasone—rheumatoid arthritis	1.43e-05	0.000352	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	1.42e-05	0.000351	CcSEcCtD
Paricalcitol—Fatigue—Methotrexate—rheumatoid arthritis	1.42e-05	0.000351	CcSEcCtD
Paricalcitol—Headache—Betamethasone—rheumatoid arthritis	1.42e-05	0.00035	CcSEcCtD
Paricalcitol—Headache—Dexamethasone—rheumatoid arthritis	1.42e-05	0.00035	CcSEcCtD
Paricalcitol—Asthenia—Prednisone—rheumatoid arthritis	1.41e-05	0.000349	CcSEcCtD
Paricalcitol—Pain—Methotrexate—rheumatoid arthritis	1.41e-05	0.000348	CcSEcCtD
Paricalcitol—Pruritus—Prednisone—rheumatoid arthritis	1.4e-05	0.000345	CcSEcCtD
Paricalcitol—Feeling abnormal—Methotrexate—rheumatoid arthritis	1.36e-05	0.000335	CcSEcCtD
Paricalcitol—Diarrhoea—Prednisone—rheumatoid arthritis	1.35e-05	0.000333	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	1.35e-05	0.000333	CcSEcCtD
Paricalcitol—Nausea—Betamethasone—rheumatoid arthritis	1.35e-05	0.000332	CcSEcCtD
Paricalcitol—Nausea—Dexamethasone—rheumatoid arthritis	1.35e-05	0.000332	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	1.31e-05	0.0012	CbGpPWpGaD
Paricalcitol—Urticaria—Methotrexate—rheumatoid arthritis	1.31e-05	0.000323	CcSEcCtD
Paricalcitol—Dizziness—Prednisone—rheumatoid arthritis	1.3e-05	0.000322	CcSEcCtD
Paricalcitol—Body temperature increased—Methotrexate—rheumatoid arthritis	1.3e-05	0.000322	CcSEcCtD
Paricalcitol—Abdominal pain—Methotrexate—rheumatoid arthritis	1.3e-05	0.000322	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—BGN—rheumatoid arthritis	1.3e-05	0.00118	CbGpPWpGaD
Paricalcitol—Vomiting—Prednisone—rheumatoid arthritis	1.25e-05	0.00031	CcSEcCtD
Paricalcitol—Rash—Prednisone—rheumatoid arthritis	1.24e-05	0.000307	CcSEcCtD
Paricalcitol—Dermatitis—Prednisone—rheumatoid arthritis	1.24e-05	0.000307	CcSEcCtD
Paricalcitol—Headache—Prednisone—rheumatoid arthritis	1.24e-05	0.000305	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—ENO1—rheumatoid arthritis	1.22e-05	0.00111	CbGpPWpGaD
Paricalcitol—Hypersensitivity—Methotrexate—rheumatoid arthritis	1.21e-05	0.0003	CcSEcCtD
Paricalcitol—VDR—Gene Expression—UBE2D1—rheumatoid arthritis	1.2e-05	0.00109	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.2e-05	0.00109	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ALOX5—rheumatoid arthritis	1.19e-05	0.00109	CbGpPWpGaD
Paricalcitol—Asthenia—Methotrexate—rheumatoid arthritis	1.18e-05	0.000292	CcSEcCtD
Paricalcitol—Nausea—Prednisone—rheumatoid arthritis	1.17e-05	0.000289	CcSEcCtD
Paricalcitol—Pruritus—Methotrexate—rheumatoid arthritis	1.17e-05	0.000288	CcSEcCtD
Paricalcitol—Diarrhoea—Methotrexate—rheumatoid arthritis	1.13e-05	0.000278	CcSEcCtD
Paricalcitol—Dizziness—Methotrexate—rheumatoid arthritis	1.09e-05	0.000269	CcSEcCtD
Paricalcitol—Vomiting—Methotrexate—rheumatoid arthritis	1.05e-05	0.000259	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.05e-05	0.000954	CbGpPWpGaD
Paricalcitol—Rash—Methotrexate—rheumatoid arthritis	1.04e-05	0.000257	CcSEcCtD
Paricalcitol—Dermatitis—Methotrexate—rheumatoid arthritis	1.04e-05	0.000256	CcSEcCtD
Paricalcitol—Headache—Methotrexate—rheumatoid arthritis	1.03e-05	0.000255	CcSEcCtD
Paricalcitol—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	1.03e-05	0.000939	CbGpPWpGaD
Paricalcitol—Nausea—Methotrexate—rheumatoid arthritis	9.79e-06	0.000242	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—ENO1—rheumatoid arthritis	9.73e-06	0.000886	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CAT—rheumatoid arthritis	8.76e-06	0.000798	CbGpPWpGaD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	8.35e-06	0.000761	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—NR3C1—rheumatoid arthritis	8.25e-06	0.000751	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—MTHFR—rheumatoid arthritis	7.31e-06	0.000666	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CAT—rheumatoid arthritis	7e-06	0.000638	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—POMC—rheumatoid arthritis	5.85e-06	0.000533	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—MTHFR—rheumatoid arthritis	5.85e-06	0.000532	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ALB—rheumatoid arthritis	5.33e-06	0.000486	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—FADS2—rheumatoid arthritis	5.23e-06	0.000477	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NOS3—rheumatoid arthritis	5.1e-06	0.000465	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—POMC—rheumatoid arthritis	4.67e-06	0.000426	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PTGS2—rheumatoid arthritis	4.66e-06	0.000425	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—POMC—rheumatoid arthritis	4.44e-06	0.000404	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ALB—rheumatoid arthritis	4.26e-06	0.000388	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NOS3—rheumatoid arthritis	4.08e-06	0.000371	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PTGS2—rheumatoid arthritis	3.73e-06	0.00034	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	3.49e-06	0.000318	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	3.37e-06	0.000307	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	3.17e-06	0.000289	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	3.09e-06	0.000281	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GC—rheumatoid arthritis	3.09e-06	0.000281	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	2.87e-06	0.000261	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—MED1—rheumatoid arthritis	2.52e-06	0.000229	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	2.34e-06	0.000213	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	2.34e-06	0.000213	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—BGN—rheumatoid arthritis	2.11e-06	0.000192	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	1.94e-06	0.000176	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	1.58e-06	0.000144	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CAT—rheumatoid arthritis	1.14e-06	0.000104	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	9.49e-07	8.64e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—POMC—rheumatoid arthritis	7.59e-07	6.91e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALB—rheumatoid arthritis	6.92e-07	6.3e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	6.62e-07	6.03e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	6.05e-07	5.51e-05	CbGpPWpGaD
